Enzo Biochem has received approval from the New York State Department of Health for the company's Ampiprobe molecular human papillomavirus (HPV) test.
Ampiprobe is the company's PCR-based test which can detect 14 high-risk HPV variants. The company said this approval positions it to pursue U.S. and international regulatory approvals.
